---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-005456"
form_type: "8-K"
ticker: "FBLG"
cik: "0001958777"
company_name: "FibroBiologics, Inc."
filed_at: "2025-02-07T23:59:59+00:00"
generated_at: "2026-05-27T01:05:12.578024+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# FibroBiologics issues shares under $15M SEPA; converts $2.9M note principal

## Summary
- Issued 118,991 shares as commitment fee at $2.1010/share on Jan 7, 2025.
- Investor converted $900K, $500K, $500K, and $1.1M of Second Note between Jan 23 and Feb 7.
- Conversion prices ranged $1.4955 to $1.6301; total shares issued: 1,936,628.
- Second Note remaining principal is $2.0M as of Feb 7, 2025.
- Sale relied on Section 4(a)(2) exemption; no public offering.

## SEC filing metadata
- accession: 0001493152-25-005456
- form_type: 8-K
- ticker: FBLG
- cik: 0001958777
- company_name: FibroBiologics, Inc.
- filed_at: 2025-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/0001493152-25-005456-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-005456
- JSON: https://secwatch.observer/filing/0001493152-25-005456.json
- Plain text: https://secwatch.observer/filing/0001493152-25-005456.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.